Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Nasopharyngeal Carcinoma 12Esophageal Neoplasms 9Esophageal Squamous Cell Carcinoma 8Squamous Cell Carcinoma of Head and Neck 7Uterine Cervical Neoplasms 6Pancreatic Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Recurrence 2Pancreatic cancer, adult 2Lung Neoplasms 2Diffuse Intrinsic Pontine Glioma 2Uterine Cervical Dysplasia 1Squamous Cell Carcinoma of Anal Canal 1Penile Neoplasms 1Pathologic Complete Response 1Pancreatic Cancer Resectable 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Meningeal Carcinomatosis 1Locally Advanced Rectal Cancer 1Hypopharyngeal Neoplasms 1HCC 1Glioma 1Glioblastoma 1Esophageal 1Colorectal Neoplasms 1Childhood Brain Stem Neoplasm 1

Interventions

Cisplatin 24Carboplatin 19Paclitaxel 18pembrolizumab 12Gemcitabine 12Radiotherapy 9Fluorouracil 9Specimen Handling 8Magnetic Resonance Spectroscopy 7cemiplimab 6Platinum 6Nivolumab 6Docetaxel 6Cetuximab 61,2-diaminocyclohexaneplatinum II citrate 6epothilone B 5anlotinib 5Sunitinib 5Pemetrexed 5Oxaliplatin 5Everolimus 5Drug Therapy 5Cyclophosphamide 5Capecitabine 5Bevacizumab 5durvalumab 4Radiotherapy, Intensity-Modulated 4Radiation 4Erlotinib Hydrochloride 4Celecoxib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma × nimotuzumab × Clear all
NCT01301612 2014-07-14

Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)

Eurofarma Laboratorios S.A.

Phase 2 Withdrawn
Tumor-Agnostic

Adenocarcinoma, Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡